XML 11 R5.htm IDEA: XBRL DOCUMENT v3.26.3
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:        
Net loss     $ (101,526,000) $ (76,675,000)
Adjustments to reconcile net loss to net cash used in operating activities:        
Share-based compensation expense $ 1,765,000 $ 1,773,000 5,528,000 6,660,000
Depreciation and amortization 2,056,000 2,306,000 7,128,000 6,936,000
Accretion and amortization of premiums and (discounts) on investments, net     (1,472,000) (3,725,000)
Realized gain on investments       (43,000)
Impairment of property and equipment 0 0 5,670,000 0
Impairment of right-of-use asset 0 791,000 2,378,000 791,000
Non-cash lease expense     1,551,000 1,428,000
Changes in operating assets and liabilities:        
Prepaid expenses and other assets     1,490,000 1,278,000
Operating lease liabilities     (4,383,000) (3,639,000)
Accounts payable and accrued and other liabilities     5,378,000 (63,000)
Net cash used in operating activities     (78,258,000) (67,052,000)
Cash flows from investing activities:        
Purchases of property and equipment     (1,841,000) (648,000)
Sale of equipment     100,000  
Purchases of investments     (106,301,000) (147,149,000)
Maturities of investments     194,195,000 247,013,000
Net cash provided by investing activities     86,153,000 99,216,000
Cash flows from financing activities:        
Proceeds from stock option exercises     752,000  
Proceeds from employee stock purchase plan purchases     73,000 77,000
Net cash provided by financing activities     825,000 77,000
Net increase in cash, cash equivalents, and restricted cash     8,720,000 32,241,000
Cash, cash equivalents, and restricted cash beginning of period     42,377,000 30,616,000
Cash, cash equivalents, and restricted cash end of period 51,097,000 62,857,000 51,097,000 62,857,000
Reconciliation of cash, cash equivalents and restricted cash to the balance sheet:        
Cash and cash equivalents 48,354,000 60,114,000 48,354,000 60,114,000
Restricted cash 2,743,000 2,743,000 2,743,000 2,743,000
Total cash, cash equivalents and restricted cash $ 51,097,000 $ 62,857,000 51,097,000 62,857,000
Supplemental disclosures of non-cash investing and financing activities:        
Acquisitions of property and equipment in accounts payable and accrued and other current liabilities     $ 221,000 $ 155,000